Basic and translational researchers at UPMC Hillman Cancer Center work closely with physician-scientists and clinicians to quickly move the most promising research results from their labs into clinical trials. While the conduct of clinical studies provides critical information to researchers that can be taken back to the lab for further study and improvement, they also provide patients with early access to the most cutting-edge and innovative cancer treatments available.
Watch Edward Chu, MD, Deputy Director of UPMC Hillman Cancer Center, Chief of Hematology-Oncology, and Co-Leader of the Hillman Cancer Therapeutics Program, discuss how clinical trials are advancing the way cancer patients are treated.
The post Clinical Trials at UPMC Hillman Cancer Center appeared first on UPMC Hillman Cancer Center.
